Search Results 91-100 of 15525 for Humira

  1. Auranofin in Decreasing Pain in Patients With Paclitaxel-Induced Pain Syndrome - Mayo Clinic

    This randomized pilot trial studies whether auranofin will relieve pain following paclitaxel in patients who have previously experienced paclitaxel-induced pain ...

  2. A Second Trial of the Abbreviated Protocol Two-Stage Exchange - Mayo Clinic

    ... (Humira) Tocilizumab (Actemra) Etenercept (Enbrel) Anakinra (Kineret) Golimumab (Simponi) Secukinimab (Cosentyx) Infliximab (Remicade) Ustekinumab (Stelara) ...

  3. A Study to Evaluate the Safety and Effectiveness of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa Evaluating the Safety and Effectiveness of PF-06650833, PF-06700841, and PF-06826647 in Adults with Moderate-to-Severe Hidradenitis Suppurativa - Mayo Clinic

    adalimumab (Humira®): 6 weeks;; infliximab (Remicade®), golimumab (Simponi®): 10 weeks;; certolizumab pegol (Cimzia®): 12 weeks. Participant must agree to ...

  4. Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy - Mayo Clinic

    About this study. The purpose of this study is to determine whether adding low dose methotrexate to anti -TNF therapy is more effective than treatment with ...

  5. A Study of the Effectiveness and Safety of Vedolizumab Compared to Adalimumab for Participants with Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of vedolizumab intravenous (IV) treatment compared to adalimumab subcutaneous (SC) ...

  6. Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

  7. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

    The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...

  8. Meditation. Yoga. Massage. Acupuncture. Use of supplements, such as vitamins, herbs and minerals. Music therapy. Integrative medicine aims to fit each ...

  9. Shared Biorepository for the Investigation of Inflammatory Arthritis at Mayo Clinic and University of Massachusetts

    The purpose of this study is to establish a comparator cohort of patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and other ...

  10. An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...